脑恶性胶质瘤术后联合放化疗的疗效观察-肿瘤资讯与疾病分类-中国癌症网 关键词】 替莫唑胺胶囊;脑恶性胶质瘤;生存时间;安全性 [gap=1296]Key words:temozolomide;malignant glioma;survival time ;safety
基于16个网页-相关网页
The model constituted of 3912.7851, 8930.644 is able to distinguish brainmetastasis and malignant glioma.2.
结论:1.3912.7851,8930.644的2个峰质荷比峰的组合可以用于脑恶性胶质瘤与脑转移瘤的鉴别诊断。
参考来源 - 脑恶性胶质瘤患者脑脊液中候选肿瘤标记物蛋白质峰值研究·2,447,543篇论文数据,部分数据来源于NoteExpress
目的探讨脑恶性胶质瘤长期生存患者的主要治疗方法和安全性。
Objective to evaluate the main treatment methods and safety for long-time survival patients of glioblastoma.
背景与目的:探讨NDV(新城鸡瘟病毒)修饰的瘤苗治疗脑恶性胶质瘤的疗效。
BACKGROUND AND AIM: to evaluate the therapeutical effect of autologous Newcastle_Disease_Virus (NDV) modified tumor cell vaccine in the treatment of malignant gliomas.
目的通过对比观察脑恶性胶质瘤术后替莫唑胺胶囊联合外放射治疗的疗效及安全性。
Objective To compare the curative effects and safety of temozolomide plus radiotherapy in the treatment of post-operative malignant glioma.
应用推荐